IPO Update: Mid-Year Average Return Deceptively Positive In Down Market

Outlier Leads To 25% Gain For 2022 Offerings

 
• By Mandy Jackson
  
3d illustration inflation and deflation graph
Excluding the top two performers, the average return dropped from 25% to -33% • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Financing

More from Business